{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:56:10Z","timestamp":1791968170388,"version":"4.3.4"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00587","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:36:53Z","timestamp":1566347813000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Responder Analysis of a Multicomponent Non-Pharmacological Intervention (MAKS) for People With Cognitive Impairment in the German Day-Care Study (DeTaMAKS)"],"prefix":"10.3389","volume":"10","author":[{"given":"Katharina","family":"Luttenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Graessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa-Marie","family":"Behrndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"\u00d6zbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Donath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Scheel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"B1","volume-title":"Towards a dementia plan: a WHO guide","year":"2018"},{"key":"B2","volume-title":"Dementia. A public health priority","year":"2012"},{"key":"B3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol"},{"key":"B4","unstructured":"Final Appraisal Determination. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109484","article-title":"Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in London","volume":"9","author":"Perera","year":"2014","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.43","article-title":"Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study","volume":"169","author":"Gill","year":"2009","journal-title":"Arch Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200825080-00007","article-title":"Defining treatment response to donepezil in Alzheimer\u2019s disease","volume":"25","author":"Burns","year":"2008","journal-title":"Drugs Aging"},{"key":"B8","unstructured":"Dementia: assessment, management and support for people living with dementia and their carers"},{"key":"B9","unstructured":"S3-Leitlinie \"Demenzen\" (Langversion - Januar 2016)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"CD005562","DOI":"10.1002\/14651858.CD005562.pub2","article-title":"Cognitive stimulation to improve cognitive functioning in people with dementia","author":"Woods","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160683","article-title":"Effects of short-term exercise interventions on behavioral and psychological symptoms in patients with dementia: a systematic review","volume":"55","author":"Fleiner","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006489.pub4","article-title":"Exercise programs for people with dementia","author":"Forbes","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e010767","DOI":"10.1136\/bmjopen-2015-010767","article-title":"Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews","volume":"6","author":"Laver","year":"2016","journal-title":"BMJ Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000316119","article-title":"Nonpharmacological therapies in Alzheimer\u2019s disease: a systematic review of efficacy","volume":"30","author":"Olazar\u00e1n","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180980","article-title":"Immediate intervention effects of standardized multicomponent group interventions on people with cognitive impairment: a systematic review","volume":"67","author":"\u00d6zbe","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1741-7015-9-129","article-title":"Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomised, controlled trial","volume":"9","author":"Graessel","year":"2011","journal-title":"BMC Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1471-2377-12-151","article-title":"Are the effects of a non-drug multimodal activation therapy of dementia sustainable? follow-up study 10 months after completion of a randomised controlled trial","volume":"12","author":"Luttenberger","year":"2012","journal-title":"BMC Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3238\/arztebl.2017.0815","article-title":"Non-pharmacological treatment in people with cognitive impairment: results from the randomized controlled german day care study","volume":"114","author":"Straubmeier","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0946-1","article-title":"A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"61","author":"Raschetti","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"B20","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","year":"1992"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2702.2009.02990.x","article-title":"Perceived barriers to physical activity among older adults residing in long-term care institutions","volume":"19","author":"Chen","year":"2010","journal-title":"J Clin Nurs"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/48.4.S204","article-title":"Measurement of need for assistance with daily activities: quantifying the influence of gender roles","volume":"48","author":"Allen","year":"1993","journal-title":"J Gerontol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/geront\/gnz063","article-title":"Personality moderates intervention effects on cognitive function: a 6-week conversation-based intervention","author":"Cerino","year":"2019","journal-title":"Gerontologist"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208581","article-title":"Depressive symptoms as a barrier to engagement in physical activity in older adults with and without Alzheimer\u2019s disease","volume":"13","author":"Watts","year":"2018","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s12913-017-2422-x","article-title":"The German day-care study: multicomponent non-drug therapy for people with cognitive impairment in day-care centres supplemented with caregiver counselling (DeTaMAKS) \u2013 study protocol of a cluster-randomised controlled trial","volume":"17","author":"Behrndt","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2318-14-23","article-title":"Subjective caregiver burden: validity of the 10-item short version of the Burden Scale for Family Caregivers BSFC-s","volume":"14","author":"Graessel","year":"2014","journal-title":"BMC Geriatr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1026\/1616-3443.35.4.296","article-title":"Berliner Inventar zur Angeh\u00f6rigenbelastung - Demenz (BIZA-D)","volume":"35","author":"Zank","year":"2006","journal-title":"Z Klin Psychol Psychother"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"CD010783","DOI":"10.1002\/14651858.CD010783.pub2","article-title":"Mini-Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI)","volume":"3","author":"Arevalo-Rodriguez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12877-016-0271-9","article-title":"Validation of the Erlangen Test of Activities of daily living in persons with Mild Dementia or Mild Cognitive Impairment (ETAM)","volume":"16","author":"Luttenberger","year":"2016","journal-title":"BMC Geriatr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/089198879600900106","article-title":"Longitudinal changes in cognitive functioning in adult day care participants","volume":"9","author":"Cohen-Mansfield","year":"1996","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.8.1225","article-title":"Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations","volume":"40","author":"Salmon","year":"1990","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.06.020","article-title":"Net gain analysis, an addition to responder analysis\u2014the case of antipsychotic treatment of acute mania","volume":"73","author":"Welten","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610215000289","article-title":"Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer\u2019s disease","volume":"27","author":"Droogsma","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7512.321","article-title":"Cholinesterase inhibitors for patients with Alzheimer\u2019s disease: systematic review of randomised clinical trials","volume":"331","author":"Kaduszkiewicz","year":"2005","journal-title":"BMJ"},{"key":"B39","unstructured":"Patient reported outcome measures: use in medical product development to support labeling claims"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1382042","article-title":"Versorgungsforschung - evidenzbasiert. Ein Kurz\u00fcberblick und Implikationen [Evidence-based health services research - A short review and implications]","volume":"77","author":"Gr\u00e4\u00dfel","year":"2015","journal-title":"Gesundheitswesen"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2004.00234.x","article-title":"Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life","volume":"18","author":"Wiklund","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"B42","article-title":"Der Stellenwert von patient reported outcomes (PRO) im Kontext von Health Technology Assessment (HTA)","volume-title":"Schriftenreihe Health Technology Assessment (HTA)","author":"Brettschneider","year":"2011"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:36:57Z","timestamp":1566347817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":42,"alternative-id":["10.3389\/fpsyt.2019.00587"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00587","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"article-number":"587"}}